Biomarkers for Treatment Response in Rheumatoid Arthritis: Where are they?

Sizheng Steven Zhao^{1

2}, Robert J Moots^{1

3}

Affiliations

¹ Department of Rheumatology, Liverpool University Hospitals, Liverpool, UK.
² Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
³ Faculty of Health, Social Care and Medicine, Edge Hill University, Liverpool, UK.

Editorial

Sizheng Steven Zhao et al. Rheumatol Immunol Res. 2020.

. 2020 Dec 1;1(1):1-3.

doi: 10.2478/rir-2020-0008. eCollection 2020 Dec.

Sizheng Steven Zhao^{1

2}, Robert J Moots^{1

3}

¹ Department of Rheumatology, Liverpool University Hospitals, Liverpool, UK.
² Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
³ Faculty of Health, Social Care and Medicine, Edge Hill University, Liverpool, UK.

No abstract available

Conflict of interest statement

Conflict of Interest None declared.

1. Teitsma XM, Jacobs JWG, Welsing PMJ. et al. Inadequate Response to Treat-to-Target Methotrexate Therapy in Patients With New-Onset Rheumatoid Arthritis: Development and Validation of Clinical Predictors. Ann Rheum Dis. 2018;77(9):1261–1267. - PubMed
1. Wijbrandts CA, Tak PP. Prediction of Response to Targeted Treatment in Rheumatoid Arthritis. Mayo Clin Proc. 2017;92(7):1129–1143. - PubMed
1. Plant D, Wilson AG, Barton A. Genetic and Epigenetic Predictors of Responsiveness to Treatment in RA. Nat Rev Rheumatol. 2014;10(6):329–337. - PubMed
1. Cherlin S, Plant D, Taylor JC. et al. Prediction of Treatment Response in Rheumatoid Arthritis Patients Using Genome-wide SNP Data. Genet Epidemiol. 2018;42(8):754–771. - PMC - PubMed
1. Humby FC, Al Balushi F, Lliso G, Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis? Front Med [Internet] 2017. May 3, [cited 2020 Jun 28];4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413506/ - PMC - PubMed